These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 4403972)

  • 1. Neuromuscular blocking and ganglion blocking activities of some acetylcholine antagonists in the cat.
    Bowman WC; Webb SN
    J Pharm Pharmacol; 1972 Oct; 24(10):762-72. PubMed ID: 4403972
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of action of neostigmine at the neuromuscular junction.
    Webb SN
    J Pharm Pharmacol; 1971 Dec; 23():227S-228S. PubMed ID: 4401479
    [No Abstract]   [Full Text] [Related]  

  • 3. The interactions of neuromuscular blocking agents in man: the role of hexafluorenium.
    Torda TA; Foldes FF; Bailey RJ; Klonymus DH; Kuwabara S
    Anesthesiology; 1967; 28(6):1010-9. PubMed ID: 4383425
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects on non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats.
    Hughes R; Chapple DJ
    Br J Anaesth; 1976 Feb; 48(2):59-68. PubMed ID: 130154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pre-and post-junctional cholinoceptors in the action of neostigmine at the neuromuscular junction.
    Webb SN; Bowman WC
    Clin Exp Pharmacol Physiol; 1974; 1(2):123-34. PubMed ID: 4458990
    [No Abstract]   [Full Text] [Related]  

  • 6. Ganglion-blocking activity of bisquaternary ammonium salts derived from 3 ,12 -diamino-5 -cholane and 3 ,12 -diamino-24-nor-5 -cholane.
    Marshall IG; Martin-Smith M
    Eur J Pharmacol; 1972 Jan; 17(1):39-43. PubMed ID: 4401433
    [No Abstract]   [Full Text] [Related]  

  • 7. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block.
    Waud BE; Waud DR
    Anesthesiology; 1971 Nov; 35(5):456-64. PubMed ID: 4329144
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine.
    Miller RD; Larson CP; Way WL
    Anesthesiology; 1972 Nov; 37(5):503-9. PubMed ID: 4263447
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of anaesthetics and their interactions with neuromuscular blocking agents in cats.
    Hughes R
    Br J Anaesth; 1970 Oct; 42(10):826-33. PubMed ID: 4248885
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of some guanidine derivatives on neuromuscular and ganglionic transmission.
    BARZAGHI F; MANTEGAZZA P; RIVA M
    Br J Pharmacol Chemother; 1962 Dec; 19(3):414-26. PubMed ID: 13969800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies on the site of action of nicotinic blocking drugs.
    Gandiha A; Lord JA; Marshall IG
    Eur J Pharmacol; 1973 Aug; 23(2):211-5. PubMed ID: 4147440
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of preganglionic nerve stimulation on sensitivity of the superior cervical ganglion to nicotinic blocking agents.
    Alkadhi KA; McIsaac RJ
    Br J Pharmacol; 1974 Aug; 51(4):533-9. PubMed ID: 4155976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency and onset of action of neuromuscular blocking drugs.
    Wierda JM; van den Broek L; Schiere S; Maestrone E
    Anesth Analg; 1995 Jun; 80(6):1249-50. PubMed ID: 7762863
    [No Abstract]   [Full Text] [Related]  

  • 14. On the pharmacology of Org 6338 (2beta, 16beta-dipiperidino - 5alpha - androstan - 3alpha - ol acetate dimethobromide), a new steroidal neuromuscular blocking agent.
    Sugrue MF; Duff N; McIndewar I
    J Pharm Pharmacol; 1975 Oct; 27(10):721-7. PubMed ID: 52704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments.
    Buckett WR; Hewett CL; Savage DS
    J Med Chem; 1973 Oct; 16(10):1116-24. PubMed ID: 4356139
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetanic fade during partial transmission failure produced by non-depolarizing neuromuscular blocking drugs in the cat.
    Bowman WC; Webb SN
    Clin Exp Pharmacol Physiol; 1976; 3(6):545-55. PubMed ID: 188580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal by atropine of tetanic fade induced in cats by antinicotinic and anticholinesterase agents.
    Alves-do-Prado W; Corrado AP; Prado WA
    Anesth Analg; 1987 Jun; 66(6):492-6. PubMed ID: 2883915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of onset and offset of neuromuscular block in the isolated rat diaphragm.
    Brookes N; Mackay D
    Br J Pharmacol; 1971 Feb; 41(2):339-43. PubMed ID: 4252231
    [No Abstract]   [Full Text] [Related]  

  • 19. [A nondepolarizing muscle relaxant with rapidly developing and short-term action].
    Danilov AF; Zhabko EP
    Eksp Klin Farmakol; 1998; 61(5):18-20. PubMed ID: 9854626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-nicotinic transmission during ganglionic block with chlorisondamine and nicotine.
    Alkadhi KA; McIsaac RJ
    Eur J Pharmacol; 1973 Oct; 24(1):78-85. PubMed ID: 4148299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.